Cargando…

Variability of the rs333 in Polish patients with lupus erythematosus

INTRODUCTION: Lupus erythematosus (LE) is an autoimmune disease with a strong influence of genetic and environmental factors. C-C motif chemokine receptor 5 (CCR5) gene expression may affect the development and intensity of LE. AIM: To evaluate the possible association between the 32bp deletion in r...

Descripción completa

Detalles Bibliográficos
Autores principales: Mlicka, Dominika, Duleba, Anna, Czajkowski, Rafał, Gawrych, Mariusz, Woźniacka, Anna, Robak, Ewa, Gorzkiewicz, Marta, Kozłowski, Szymon, Grzybowski, Tomasz, Skonieczna, Katarzyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362790/
https://www.ncbi.nlm.nih.gov/pubmed/34408579
http://dx.doi.org/10.5114/ada.2021.104288
_version_ 1783738237872766976
author Mlicka, Dominika
Duleba, Anna
Czajkowski, Rafał
Gawrych, Mariusz
Woźniacka, Anna
Robak, Ewa
Gorzkiewicz, Marta
Kozłowski, Szymon
Grzybowski, Tomasz
Skonieczna, Katarzyna
author_facet Mlicka, Dominika
Duleba, Anna
Czajkowski, Rafał
Gawrych, Mariusz
Woźniacka, Anna
Robak, Ewa
Gorzkiewicz, Marta
Kozłowski, Szymon
Grzybowski, Tomasz
Skonieczna, Katarzyna
author_sort Mlicka, Dominika
collection PubMed
description INTRODUCTION: Lupus erythematosus (LE) is an autoimmune disease with a strong influence of genetic and environmental factors. C-C motif chemokine receptor 5 (CCR5) gene expression may affect the development and intensity of LE. AIM: To evaluate the possible association between the 32bp deletion in rs333 locus located within the CCR5 gene and the development of LE or the occurrence of various clinical symptoms in the course of the disease. MATERIAL AND METHODS: One hundred and twenty patients with LE (77 with systemic lupus erythematosus (SLE) and 43 with discoid lupus erythematosus (DLE)) and 100 healthy controls from the Polish population were genotyped for deletion in rs333. RESULTS: 32 bp deletion in the rs333 was significantly more frequent among healthy individuals than DLE patients. Moreover, heterozygotes and homozygotes with deletion in rs333 were significantly more frequent within the control group than the group of patients with discoid lupus erythematosus. In contrast, any statistically significant differences in allele or genotype frequencies between healthy persons and SLE patients were observed. Furthermore, nucleotide sequence variability of rs333 was not associated with certain clinical symptoms of LE patients. CONCLUSIONS: Deletion in the rs333 might be a protective factor for DLE, but not SLE in the Polish population. Nevertheless further studies performed on larger populations are needed to confirm these observations.
format Online
Article
Text
id pubmed-8362790
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-83627902021-08-17 Variability of the rs333 in Polish patients with lupus erythematosus Mlicka, Dominika Duleba, Anna Czajkowski, Rafał Gawrych, Mariusz Woźniacka, Anna Robak, Ewa Gorzkiewicz, Marta Kozłowski, Szymon Grzybowski, Tomasz Skonieczna, Katarzyna Postepy Dermatol Alergol Original Paper INTRODUCTION: Lupus erythematosus (LE) is an autoimmune disease with a strong influence of genetic and environmental factors. C-C motif chemokine receptor 5 (CCR5) gene expression may affect the development and intensity of LE. AIM: To evaluate the possible association between the 32bp deletion in rs333 locus located within the CCR5 gene and the development of LE or the occurrence of various clinical symptoms in the course of the disease. MATERIAL AND METHODS: One hundred and twenty patients with LE (77 with systemic lupus erythematosus (SLE) and 43 with discoid lupus erythematosus (DLE)) and 100 healthy controls from the Polish population were genotyped for deletion in rs333. RESULTS: 32 bp deletion in the rs333 was significantly more frequent among healthy individuals than DLE patients. Moreover, heterozygotes and homozygotes with deletion in rs333 were significantly more frequent within the control group than the group of patients with discoid lupus erythematosus. In contrast, any statistically significant differences in allele or genotype frequencies between healthy persons and SLE patients were observed. Furthermore, nucleotide sequence variability of rs333 was not associated with certain clinical symptoms of LE patients. CONCLUSIONS: Deletion in the rs333 might be a protective factor for DLE, but not SLE in the Polish population. Nevertheless further studies performed on larger populations are needed to confirm these observations. Termedia Publishing House 2021-03-10 2021-02 /pmc/articles/PMC8362790/ /pubmed/34408579 http://dx.doi.org/10.5114/ada.2021.104288 Text en Copyright © 2021 Termedia https://creativecommons.org/licenses/by-nc-sa/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0). License (http://creativecommons.org/licenses/by-nc-sa/4.0/ (https://creativecommons.org/licenses/by-nc-sa/4.0/) )
spellingShingle Original Paper
Mlicka, Dominika
Duleba, Anna
Czajkowski, Rafał
Gawrych, Mariusz
Woźniacka, Anna
Robak, Ewa
Gorzkiewicz, Marta
Kozłowski, Szymon
Grzybowski, Tomasz
Skonieczna, Katarzyna
Variability of the rs333 in Polish patients with lupus erythematosus
title Variability of the rs333 in Polish patients with lupus erythematosus
title_full Variability of the rs333 in Polish patients with lupus erythematosus
title_fullStr Variability of the rs333 in Polish patients with lupus erythematosus
title_full_unstemmed Variability of the rs333 in Polish patients with lupus erythematosus
title_short Variability of the rs333 in Polish patients with lupus erythematosus
title_sort variability of the rs333 in polish patients with lupus erythematosus
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362790/
https://www.ncbi.nlm.nih.gov/pubmed/34408579
http://dx.doi.org/10.5114/ada.2021.104288
work_keys_str_mv AT mlickadominika variabilityofthers333inpolishpatientswithlupuserythematosus
AT dulebaanna variabilityofthers333inpolishpatientswithlupuserythematosus
AT czajkowskirafał variabilityofthers333inpolishpatientswithlupuserythematosus
AT gawrychmariusz variabilityofthers333inpolishpatientswithlupuserythematosus
AT wozniackaanna variabilityofthers333inpolishpatientswithlupuserythematosus
AT robakewa variabilityofthers333inpolishpatientswithlupuserythematosus
AT gorzkiewiczmarta variabilityofthers333inpolishpatientswithlupuserythematosus
AT kozłowskiszymon variabilityofthers333inpolishpatientswithlupuserythematosus
AT grzybowskitomasz variabilityofthers333inpolishpatientswithlupuserythematosus
AT skoniecznakatarzyna variabilityofthers333inpolishpatientswithlupuserythematosus